 |
 |
||||||
 |
Commentaires de nos clients |
Votre panier
€0.00 (0 articles)
| |||||
Générique Ezetimibe - Vytorin, Zetia
|
| ||||||||||||
- FDA approved Tadalafil medication for the treatment of erectile dysfunction accompanied with primary and secondary symptoms of benign prostatic hyperplasia (BPH) in men above 45 years.
Considering the information of three randomized, multicenter, double, blind clinical studies and a retrospective analysis of the medical documentation, FDA approved on October 7, 2011 Tadalafil medication for the treatment of erectile dysfunction accompanied with primary and secondary symptoms of benign prostatic hyperplasia (BPH) in men above 45 years.
- The forming, development and monitoring of the pharmaceutical market in USA in September 2011
In spite of low rates and stagnation of industrial development, the pharmaceutical market shows a dynamical growth.
- Sildenafil citrate and pulmonary arterial hypertension
Pulmonary arterial hypertension Definition “pulmonary arterial hypertension” is related to a group of diseases characterized by: - Progressive increase in pulmonary vascular resistance; - Reduction in pulmonary bloodflow; - High pulmonary artery pressure; - Contractility of the heart right ventricle; - Right ventricular failure.
- Fruit and vegetables do not reduce overall cancer risk, review concludes
Eating lots of fruit and vegetables will do little to reduce your risk of developing cancer, according to a review of a decade of research involving more than a million people.
- Common painkillers could be linked to male reproductive disorder
The use of mild painkillers, such as paracetamol, in pregnancy – previously considered harmless to the baby in the womb – could be a major factor in the rise of male reproductive disorders, according to a study.
Notre page de facturation est certifiée par:
- Sanofi and Regeneron Announce Publication of Positive Phase 2 Results for ... - MarketWatch (press release)
Sanofi and Regeneron Announce Publication of Positive Phase 2 Results for .
- Did FDA's Vytorin warning negatively impact health outcomes? - Medical Marketing and Media
Did FDA's Vytorin warning negatively impact health outcomes?Medical Marketing and MediaA new study found a substantial uptick in nonadherence rates in the months after the FDA issued a caution about Merck/Schering-Plough's ezetimibe.
- CVS Caremark Sponsored Research Finds FDA Drug Warnings Can Have Immediate ... - MarketWatch (press release)
CVS Caremark Sponsored Research Finds FDA Drug Warnings Can Have Immediate .
- Merck Wins Two Patent Lawsuits - New York Times
Merck Wins Two Patent LawsuitsNew York TimesBoth lawsuits concern the patent for ezetimibe, Zetia's active ingredient and a part of Vytorin, which also includes generic Zocor.
- Merck wins patent fight on Zetia, Vytorin; Fitch warns of 'pure pharma' risks; - FiercePharma
Merck wins patent fight on Zetia, Vytorin; Fitch warns of 'pure pharma' risks;FiercePharmaArticle | Follow @FiercePharma > A US court upheld Merck's ($MRK) patent on the active ingredient ezetimibe, marketed as the cholesterol-lowering Zetia and in the combo cholesterol pill Vytorin.
|
| Copyright © 2005-2010 Canadian Pharmacy Online Canada Pharmacy, Canadian Pharmacy. |